These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9458979)

  • 21. Comparative in vitro fungicidal activity of echinocandins against Candida albicans in peritoneal dialysis fluids.
    Tobudic S; Forstner C; Schranz H; Poeppl W; Vychytil A; Burgmann H
    Mycoses; 2013 Nov; 56(6):623-30. PubMed ID: 23551835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Caspofungin susceptibility testing of Candida inconspicua: correlation of different methods with the minimal fungicidal concentration.
    Majoros L; Kardos G; Szabó B; Sipiczki M
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3486-8. PubMed ID: 16048965
    [TBL] [Abstract][Full Text] [Related]  

  • 23. National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.
    Takakura S; Fujihara N; Saito T; Kudo T; Iinuma Y; Ichiyama S
    J Antimicrob Chemother; 2004 Feb; 53(2):283-9. PubMed ID: 14688039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of a Long-Acting Echinocandin (CD101) and Seven Comparator Antifungal Agents Tested against a Global Collection of Contemporary Invasive Fungal Isolates in the SENTRY 2014 Antifungal Surveillance Program.
    Pfaller MA; Messer SA; Rhomberg PR; Castanheira M
    Antimicrob Agents Chemother; 2017 Mar; 61(3):. PubMed ID: 28052853
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Comparison of the fungicidal activities of caspofungin and amphotericin B against Candida glabrata.
    Barchiesi F; Spreghini E; Tomassetti S; Arzeni D; Giannini D; Scalise G
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4989-92. PubMed ID: 16304162
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro pharmacodynamics of anidulafungin and caspofungin against Candida glabrata isolates, including strains with decreased caspofungin susceptibility.
    Cota J; Carden M; Graybill JR; Najvar LK; Burgess DS; Wiederhold NP
    Antimicrob Agents Chemother; 2006 Nov; 50(11):3926-8. PubMed ID: 16940061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Initial results from a longitudinal international surveillance programme for anidulafungin (2003).
    Messer SA; Kirby JT; Sader HS; Fritsche TR; Jones RN
    J Antimicrob Chemother; 2004 Dec; 54(6):1051-6. PubMed ID: 15564286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative activity in vitro of cilofungin (LY 121019) with other agents used for treatment of deep-seated Candida infections.
    Rennie RP; Hellman L
    Mycoses; 1989 Mar; 32(3):145-50. PubMed ID: 2733726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Activities of micafungin against 315 invasive clinical isolates of fluconazole-resistant Candida spp.
    Messer SA; Diekema DJ; Boyken L; Tendolkar S; Hollis RJ; Pfaller MA
    J Clin Microbiol; 2006 Feb; 44(2):324-6. PubMed ID: 16455878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the in vitro activity of echinocandins against Candida albicans, Candida dubliniensis, and Candida africana by time-kill curves.
    Gil-Alonso S; Jauregizar N; Cantón E; Eraso E; Quindós G
    Diagn Microbiol Infect Dis; 2015 May; 82(1):57-61. PubMed ID: 25703894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Examination of the in vitro fungicidal activity of echinocandins against Candida lusitaniae by time-killing methods.
    Cantón E; Pemán J; Hervás D; Espinel-Ingroff A
    J Antimicrob Chemother; 2013 Apr; 68(4):864-8. PubMed ID: 23228935
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of 50% human serum on the killing activity of micafungin against eight Candida species using time-kill methodology.
    Földi R; Szilágyi J; Kardos G; Berényi R; Kovács R; Majoros L
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):338-42. PubMed ID: 22726529
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Agar disk diffusion susceptibility tests with cilofungin (LY 121019).
    Espinel-Ingroff A; Shadomy S; White S
    J Med Vet Mycol; 1991; 29(2):93-8. PubMed ID: 1880684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence of test conditions on antifungal time-kill curve results: proposal for standardized methods.
    Klepser ME; Ernst EJ; Lewis RE; Ernst ME; Pfaller MA
    Antimicrob Agents Chemother; 1998 May; 42(5):1207-12. PubMed ID: 9593151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Difference in killing activity of caspofungin and paradoxical growth between Candida albicans and C. krusei clinical isolates in different media.
    Varga I; Sóczó G; Kardos G; Kemény-Beke A; Kelentey B; Márton I; Majoros L
    J Chemother; 2009 Feb; 21(1):36-41. PubMed ID: 19297270
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species.
    Pfaller MA; Messer SA; Mills K; Bolmström A; Jones RN
    J Clin Microbiol; 2001 Dec; 39(12):4387-9. PubMed ID: 11724849
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of in vitro susceptibility testing conditions on the anti-candidal activity of LY121019.
    Pfaller MA; Gerarden T; Yu M; Wenzel RP
    Diagn Microbiol Infect Dis; 1988 Sep; 11(1):1-9. PubMed ID: 3219817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activity of MK-0991 (L-743,872), a new echinocandin, compared with those of LY303366 and four other antifungal agents tested against blood stream isolates of Candida spp.
    Marco F; Pfaller MA; Messer SA; Jones RN
    Diagn Microbiol Infect Dis; 1998 Sep; 32(1):33-7. PubMed ID: 9791755
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of the Sensititre Yeast One microdilution method for susceptibility testing of Candida species to anidulafungin, caspofungin, and micafungin.
    García-Agudo L; García-Martos P; Martos-Cañadas J; Aznar-Marín P; Marín-Casanova P; Rodríguez-Iglesias M
    Rev Esp Quimioter; 2012 Dec; 25(4):256-60. PubMed ID: 23303256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antifungal activity of LY295337 in vitro against clinical isolates of Candida spp.
    Aller AI; Martin Mazuelos E; Morilla MD; Montero O
    Chemotherapy; 1995; 41(4):276-80. PubMed ID: 7555208
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.